Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Collichio

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The American Society of Hematology and ASCO Curricular Milestones for Assessment of Fellows in Hematology/Oncology: Development, Reflection, and Next StepsFrances Collichio, Elaine A Muchmore
Pharmacotherapy|February 26, 2013
Vemurafenib-associated pancreatitis: case reportBenyam Muluneh, Larry W Buie, Frances Collichio
The American Journal of Hospice & Palliative Care|September 5, 2008
Shackled: the challenge of caring for an incarcerated patientAndrew Courtwright, Theresa Raphael-Grimm, Frances Collichio
Clinics in Dermatology|February 27, 2013
Historical review of melanoma treatment and outcomesCarrie Lee, Frances Collichio, David Ollila, et al.
American Journal of Clinical Oncology|October 14, 2009
Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?Randall J Kimple, Sarah Grabowski, Michael Papez, et al.
Annals of Surgical Oncology|February 9, 2018
Implementing a Program of Talimogene laherparepvecFrances Collichio, Lauren Burke, Amber Proctor, et al.
Oncotargets and Therapy|November 30, 2016
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trialKevin J Harrington, Robert Hi Andtbacka, Frances Collichio, et al.
Journal for Immunotherapy of Cancer|June 8, 2019
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanomaRobert H I Andtbacka, Frances Collichio, Kevin J Harrington, et al.
The Lancet. Oncology|October 3, 2006
Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancerLester Kwock, J Keith Smith, Mauricio Castillo, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The American Society of Hematology and ASCO Curricular Milestones for Assessment of Fellows in Hematology/Oncology: Development, Reflection, and Next StepsFrances Collichio, Elaine A Muchmore
Pharmacotherapy|February 26, 2013
Vemurafenib-associated pancreatitis: case reportBenyam Muluneh, Larry W Buie, Frances Collichio
The American Journal of Hospice & Palliative Care|September 5, 2008
Shackled: the challenge of caring for an incarcerated patientAndrew Courtwright, Theresa Raphael-Grimm, Frances Collichio
Clinics in Dermatology|February 27, 2013
Historical review of melanoma treatment and outcomesCarrie Lee, Frances Collichio, David Ollila, et al.
American Journal of Clinical Oncology|October 14, 2009
Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?Randall J Kimple, Sarah Grabowski, Michael Papez, et al.
Annals of Surgical Oncology|February 9, 2018
Implementing a Program of Talimogene laherparepvecFrances Collichio, Lauren Burke, Amber Proctor, et al.
Oncotargets and Therapy|November 30, 2016
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trialKevin J Harrington, Robert Hi Andtbacka, Frances Collichio, et al.
Journal for Immunotherapy of Cancer|June 8, 2019
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanomaRobert H I Andtbacka, Frances Collichio, Kevin J Harrington, et al.
The Lancet. Oncology|October 3, 2006
Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancerLester Kwock, J Keith Smith, Mauricio Castillo, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
Pageof 3